Vasella Knocks AstraZeneca Acquisition Rumor
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis CEO Daniel Vasella dismissed rumors that the firm is considering acquisition of rival drug maker AstraZeneca July 17